TY - JOUR AU - Horstink, M. AU - Tolosa, E. AU - Bonuccelli, U. AU - Deuschl, G. AU - Friedman, A. AU - Kanovsky, P. AU - Larsen, J. P. AU - Lees, A. AU - Oertel, W. AU - Poewe, W. AU - Rascol, O. AU - Sampaio, C. PY - 2006 DA - 2006// TI - Review of the therapeutic management of Parkinson’s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part 1: early (uncomplicated) Parkinson’s disease JO - Eur J Neurol VL - 13 UR - https://doi.org/10.1111/j.1468-1331.2006.01547.x DO - 10.1111/j.1468-1331.2006.01547.x ID - Horstink2006 ER - TY - JOUR AU - Deleu, D. AU - Northway, M. G. AU - Hanssens, Y. PY - 2002 DA - 2002// TI - Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson’s disease JO - Clin Pharmacokinet VL - 41 UR - https://doi.org/10.2165/00003088-200241040-00003 DO - 10.2165/00003088-200241040-00003 ID - Deleu2002 ER - TY - JOUR AU - Bonuccelli, U. AU - Del Dotto, P. AU - Rascol, O. PY - 2009 DA - 2009// TI - Role of dopamine receptor agonists in the treatment of early Parkinson’s disease JO - Parkinsonism Relat Disord VL - 15 UR - https://doi.org/10.1016/S1353-8020(09)70835-1 DO - 10.1016/S1353-8020(09)70835-1 ID - Bonuccelli2009 ER - TY - JOUR AU - Bonuccelli, U. AU - Ceravolo, R. PY - 2008 DA - 2008// TI - The safety of dopamine agonists in the treatment of Parkinson’s disease JO - Expert Opin Drug Saf VL - 7 UR - https://doi.org/10.1517/14740338.7.2.111 DO - 10.1517/14740338.7.2.111 ID - Bonuccelli2008 ER - TY - JOUR AU - Stocchi, F. PY - 2011 DA - 2011// TI - Continuous dopaminergic stimulation and novel formulations of dopamine agonists JO - J Neurol VL - 258 UR - https://doi.org/10.1007/s00415-011-6024-y DO - 10.1007/s00415-011-6024-y ID - Stocchi2011 ER - TY - JOUR AU - Giladi, N. AU - Boroojerdi, B. AU - Korczy, A. D. AU - Burn, D. J. AU - Clarke, C. E. AU - Schapira, A. H. V. PY - 2007 DA - 2007// TI - Rotigotine transdermal patch in early Parkinson’s disease: a randomized, double-blind, controlled study versus placebo and ropinirole JO - Mov Disord VL - 22 UR - https://doi.org/10.1002/mds.21741 DO - 10.1002/mds.21741 ID - Giladi2007 ER - TY - JOUR AU - Poewe, W. AU - Rascol, O. AU - Barone, P. AU - Hauser, R. A. AU - Mizuno, Y. AU - Haaksma, M. AU - Salin, L. AU - Juhel, N. AU - Schapira, A. H. PY - 2011 DA - 2011// TI - Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial JO - Neurology VL - 77 UR - https://doi.org/10.1212/WNL.0b013e31822affb0 DO - 10.1212/WNL.0b013e31822affb0 ID - Poewe2011 ER - TY - JOUR AU - Stocchi, F. AU - Hersh, B. P. AU - Scott, B. L. AU - Nausieda, P. A. AU - Giorgi, L. PY - 2008 DA - 2008// TI - Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson’s disease: a randomized, double-blind, non-inferiority crossover study JO - Curr Med Res Opin VL - 24 UR - https://doi.org/10.1185/03007990802387130 DO - 10.1185/03007990802387130 ID - Stocchi2008 ER - TY - JOUR AU - Oertel, W. AU - LeWitt, P. AU - Giladi, N. AU - Ghys, L. AU - Grieger, F. AU - Boroojerdi, B. PY - 2013 DA - 2013// TI - Treatment of patients with early and advanced Parkinson’s disease with rotigotine transdermal system: age-relationship to safety and tolerability JO - Parkinsonism Relat Disord VL - 19 UR - https://doi.org/10.1016/j.parkreldis.2012.06.009 DO - 10.1016/j.parkreldis.2012.06.009 ID - Oertel2013 ER - TY - JOUR AU - Grosset, D. PY - 2010 DA - 2010// TI - Therapy adherence issues in Parkinson’s disease JO - J Neurol Sci VL - 289 UR - https://doi.org/10.1016/j.jns.2009.08.053 DO - 10.1016/j.jns.2009.08.053 ID - Grosset2010 ER - TY - JOUR AU - Gelb, D. J. AU - Oliver, E. AU - Gilman, S. PY - 1999 DA - 1999// TI - Diagnostic criteria for Parkinson’s disease JO - Arch Neurol VL - 56 UR - https://doi.org/10.1001/archneur.56.1.33 DO - 10.1001/archneur.56.1.33 ID - Gelb1999 ER - TY - JOUR AU - Stacy, M. AU - Bowron, A. AU - Guttman, M. AU - Hauser, R. AU - Hughes, K. AU - Larsen, J. P. AU - LeWitt, P. AU - Oertel, W. AU - Quinn, N. AU - Sethi, K. AU - Stocchi, F. PY - 2005 DA - 2005// TI - Identification of motor and nonmotor wearing-off in Parkinson’s disease: comparison of a patient questionnaire versus a clinician assessment JO - Mov Disord VL - 20 UR - https://doi.org/10.1002/mds.20383 DO - 10.1002/mds.20383 ID - Stacy2005 ER - TY - JOUR AU - Goetz, C. G. AU - Blasucci, L. AU - Stebbins, G. T. PY - 1999 DA - 1999// TI - Switching dopamine agonists in advanced Parkinson’s disease: Is rapid titration preferable to slow? JO - Neurology VL - 52 UR - https://doi.org/10.1212/WNL.52.6.1227 DO - 10.1212/WNL.52.6.1227 ID - Goetz1999 ER - TY - JOUR AU - Mizuno, Y. AU - Yamamoto, M. AU - Kuno, S. AU - Hasegawa, K. AU - Hattori, N. AU - Kagimura, T. AU - Sarashina, A. AU - Rascol, O. AU - Schapira, A. H. AU - Barone, P. AU - Hauser, R. A. AU - Poewe, W. PY - 2012 DA - 2012// TI - Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trial JO - Clin Neuropharmacol VL - 35 UR - https://doi.org/10.1097/WNF.0b013e31825f77b9 DO - 10.1097/WNF.0b013e31825f77b9 ID - Mizuno2012 ER - TY - JOUR AU - Fayard, C. AU - Bonaventure, A. AU - Benatru, I. AU - Roze, E. AU - Dumurgier, J. AU - Moisan, F. AU - Soumaré, A. AU - Houssinot, J. AU - Dupupet, J. L. AU - Mazurie, J. L. AU - Balaboi, I. AU - Houeto, J. L. AU - Krim, E. AU - Ranoux, D. AU - Goldberg, M. AU - Imbernon, E. AU - Moreau, T. AU - Giroud, M. AU - Tzourio, C. AU - Elbaz, A. PY - 2011 DA - 2011// TI - Impact of recommendations on the initial therapy of Parkinson’s disease: a population-based study in France JO - Parkinsonism Relat Disord VL - 17 UR - https://doi.org/10.1016/j.parkreldis.2011.04.020 DO - 10.1016/j.parkreldis.2011.04.020 ID - Fayard2011 ER -